Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Hospital Mater DeiBSP:MATD3 +1.61%82 Capex-to-Operating-Cash-Flow is 0.31 as of Jun. 2026, which is 67% below its 10-year median of 0.93. GuruFocus rates BSP:MATD3 with a GF Score™ of 82/100 and a GF Value™ of R$5.76 (Modestly Undervalued). The stock has 3 warning signs investors should review. Among 393 Healthcare Providers & Services companies, Hospital Mater Dei ranks better than 52.42% on this metric.
Capex-to-Operating-Cash-Flow assesses how much of a company’s cash flow from operations is being devoted to capital expenditure. It’s also useful to distinguish whether the company is capital intensive or not.
Hospital Mater Dei (BSP:MATD3) Capex-to-Operating-Cash-Flow Explanation
Capex-to-Operating-Cash-Flow ratio assesses how much of a company’s Cash Flow from Operations is being devoted to Capital Expenditure. It is a good indicator in terms of how much the company is focused on growth. In general, a high Capex-to-Operating-Cash-Flow ratio indicates that the company is investing more in physical assets and is focused on growth and expansion. Conversely, lower ratio could indicate that a company has reached maturity and is no longer pursuing aggressive growth.
Moreover, the ratio is also useful to distinguish whether the company is capital intensive or not. If the ratio is large, then the company tends to be capital intensive. Lower ratio suggests that it’s a capital-light business. The ratio can be combined with ROIC % to identify whether the company is an asset-light business that has a high return on invested capital. This is one question investors commonly ask to see if a company qualifies as a good company.
Hospital Mater Dei Capex-to-Operating-Cash-Flow Related Terms
Hospital Mater Dei Capex-to-Operating-Cash-Flow Historical Data
* Premium members only.
The historical data trend for Hospital Mater Dei's Capex-to-Operating-Cash-Flow can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Hospital Mater Dei Capex-to-Operating-Cash-Flow Chart
BSP:MATD3 vs HCA, THC, EHC: Capex-to-Operating-Cash-Flow Comparison
For the Medical Care Facilities subindustry, Hospital Mater Dei's Capex-to-Operating-Cash-Flow, along with its competitors' market caps and Capex-to-Operating-Cash-Flow data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Hospital Mater Dei Capex-to-Operating-Cash-Flow vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Hospital Mater Dei's Capex-to-Operating-Cash-Flow distribution charts can be found below:
* The bar in red indicates where Hospital Mater Dei's Capex-to-Operating-Cash-Flow falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
What does a Capex-to-Operating-Cash-Flow of 0.31 mean?
Hospital Mater Dei (BSP:MATD3) has a Capex-to-Operating-Cash-Flow of 0.31 as of Jun. 2026. Capex to Operating Cash Flow ratio assesses how much of a company’s cash flow from operations is being devoted to capital expenditure. View historical data on Hospital Mater Dei and its competitors. This is 67% below median its historical median of 0.93. Over the past decade, Hospital Mater Dei's Capex-to-Operating-Cash-Flow has ranged from 0.27 to 2.20. According to the industry distribution chart, Hospital Mater Dei ranks #187 out of 393 companies in the Healthcare Providers & Services industry, placing it in the top 47.6%.
Is Hospital Mater Dei's Capex-to-Operating-Cash-Flow too high?
Hospital Mater Dei's current Capex-to-Operating-Cash-Flow of 0.31 is 67% below median its 10-year median of 0.93. Over the past 10 years, this metric has ranged from a low of 0.27 to a high of 2.20. The Healthcare Providers & Services industry median Capex-to-Operating-Cash-Flow is 0.34. Hospital Mater Dei's value of 0.31 is 8.8% below this industry median. Based on the distribution chart, Hospital Mater Dei ranks #187 out of 393 companies in the Healthcare Providers & Services industry, which is above the industry midpoint. Overall, Hospital Mater Dei has a GF Score™ of 82/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Hospital Mater Dei's Capex-to-Operating-Cash-Flow compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Hospital Mater Dei ranks #187 out of 393 companies for Capex-to-Operating-Cash-Flow. This puts Hospital Mater Dei in the upper half of its industry. The industry median Capex-to-Operating-Cash-Flow is 0.34. Hospital Mater Dei's value of 0.31 is 8.8% below this benchmark. Historically, Hospital Mater Dei's own Capex-to-Operating-Cash-Flow has ranged from 0.27 to 2.20 over the past decade. While the company's 10-year median is 0.93 vs. the industry median of 0.34, Hospital Mater Dei has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Capex-to-Operating-Cash-Flow for a Healthcare Providers & Services company?
The median Capex-to-Operating-Cash-Flow among Healthcare Providers & Services companies is 0.34, based on 393 companies in the industry. Companies in the top quartile (top 25%) have a Capex-to-Operating-Cash-Flow significantly above this median, while those in the bottom quartile fall well below. However, Capex-to-Operating-Cash-Flow should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Hospital Mater Dei's current Capex-to-Operating-Cash-Flow of 0.31 is 8.8% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Capex-to-Operating-Cash-Flow mean?
A high Capex-to-Operating-Cash-Flow can signal that a stock is expensive relative to its fundamentals. Capex to Operating Cash Flow ratio assesses how much of a company’s cash flow from operations is being devoted to capital expenditure. View historical data on Hospital Mater Dei and its competitors. For the Healthcare Providers & Services industry, the median Capex-to-Operating-Cash-Flow is 0.34 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Hospital Mater Dei's current Capex-to-Operating-Cash-Flow is 0.31, which is 67% below median its own 10-year median of 0.93. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Hospital Mater Dei stock overvalued right now?
Based on GuruFocus' analysis, Hospital Mater Dei (BSP:MATD3) is currently considered Modestly Undervalued. The stock's GF Value™ is R$5.76, compared to a current price of R$5.06 — trading 12.2% below its estimated fair value. The current Capex-to-Operating-Cash-Flow is 0.31, which is 67% below median its 10-year median of 0.93 and 8.8% below the Healthcare Providers & Services industry median of 0.34. Hospital Mater Dei's overall GF Score™ is 82/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Capex-to-Operating-Cash-Flow calculated?
Capex-to-Operating-Cash-Flow is calculated from a company's financial statements. For Hospital Mater Dei (BSP:MATD3), the current Capex-to-Operating-Cash-Flow is 0.31 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Hospital Mater Dei (BSP:MATD3) Overvalued in 2026?
Based on GuruFocus' analysis, Hospital Mater Dei stock appears to be undervalued.
The current stock price of R$5.06 is trading 12.2% below its estimated GF Value™ of R$5.76.
GuruFocus considers Hospital Mater Dei to be Modestly Undervalued.
Key valuation signals for BSP:MATD3:
Capex-to-Operating-Cash-Flow: 0.31 (67% below median its 10-year median of 0.93)
GF Value™: R$5.76 vs. price of R$5.06 (12.2% below fair value)
Industry Position: 8.8% below the Healthcare Providers & Services median (#187 of 393)
No single metric tells the full story. See the BSP:MATD3 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Hospital Mater Dei SA is an integrated healthcare ecosystem that provides hospital and oncological services. The company provides a wide range of healthcare services, including hospitalizations, surgeries, oncology treatments, medical appointments, and diagnostic exams.
82GF Score
Get the complete analysis for BSP:MATD3
Capex-to-Operating-Cash-Flow is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BSP:MATD3 has been successfully added to your 
